Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which…
Vinge has advised Tobii AB (publ) in connection with a fully guaranteed rights issue of ordinary sha…
In total, 7.7 million shares were placed at a price of SEK 57.50 per share, corresponding to a total…
Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which wi…
Vinge has advised Annehem Fastigheter AB (publ) in connection with its rights issue of Class A and B…
Vinge has advised Annehem Fastigheter AB (publ) in connection with the acquisition of the property T…
Vinge has assisted Tobii AB in connection with the acquisition of the AutoSense business from Xperi…
In total, 8.4 million shares were placed at a price of SEK 43.50 per share, corresponding to a total…
Pursuant to the agreement, SBB Residential Property AB will issue SEK 2.36 billion of preference sha…
Vinge has advised Vicore Pharma Holding AB (publ) in connection with directed share issuances, where…
Vinge advises Biotage AB (publ) (“Biotage”) in connection with its acquisition of Astrea Bioseparati…
Vinge has advised Neobo Fastigheter AB (publ) (”Neobo”) in connection with the listing of Neobo’s sh…
Vinge has advised Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) in connection with the distribu…
Vinge has advised Vicore Pharma Holding AB (publ) in connection with a directed share issue, whereby…
Vinge has advised Azelio AB (publ) on a fully guaranteed rights issue, which will provide Azelio wit…
Vinge has advised Xspray Pharma, a pharmaceutical company with several product candidates in clinica…
Vinge has advised EQT in connection with the combination with Baring Private Equity Asia, a leading…
Vinge advises Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) in connection with its public offer…
Vinge has advised Litorina CoInvest 1 AB in conjunction with the sale of 10.5 percent of the shares…
Vinge has advised Tobii and Tobii Dynavox in connection with the distribution of the shares in Tobii…
Vinge advises Cell Impact AB (publ) in connection with a fully guaranteed rights issue which will pr…
Vinge has advised Samhällsbyggnadsbolaget i Norden AB (”SBB”) in connection with a directed share is…
Vinge has advised Samhällsbyggnadsbolaget i Norden AB (”SBB”) in connection with the sale of propert…
Vinge has advised Tobii AB in connection with a directed share issue whereby the company receives ap…
Vinge has advised Xspray Pharma, a pharmaceutical company with several product candidates in clinica…
Vinge has advised Funnel and its shareholders in conjunction with a capital procurement of USD 66 mi…
Vinge has advised Samhällsbyggnadsbolaget i Norden AB (”SBB”) in connection with its repurchase of s…
Northvolt has carried out a USD 2.75 billion private placement to finance further battery cell produ…
Vinge advises Sleep Cycle AB (publ) (“Sleep Cycle” or the “Company”) in connection with the listing…
Vinge has assisted Peab in connection with a transaction with Skistar, whereby Peab and SkiStar deep…
Vinge advised Creades AB (publ) in connection with a directed share issue of approximately SEK 1 bil…
Vinge advises Embellence Group AB (publ) (“Embellence Group”) in connection with the listing on Nasd…
Vinge has advised Vicore Pharma Holding AB (publ) in connection with a directed share issue, whereby…
Vinge has advised EQT in connection with the signing of a combination with Exeter Property Group, a…
Vinge has advised Peab and Annehem Fastigheter in connection with the distribution of the shares in…
Vinge has advised the pharmaceutical development company Xspray Pharma in connection with a directed…
Vinge has advised Cell Impact AB (publ) in connection with a directed share issue, whereby Cell Impa…
Vinge has advised the esports company G-Loot Global Esports AB (publ) in connection with its financi…
Vinge has advised Bergs Timber AB (publ) in connection with the transfer of the sawmills in Orrefors…
Vinge has advised VNV Global in connection with the process of changing the group’s domicile from Be…
Vinge has advised Equinor ASA in connection with a sale of shares in Lundin Energy AB (publ) through…
Vinge advises Xspray Pharma AB (publ) in connection with its list change from Nasdaq First North Gro…
Vinge has advised the pharmaceutical development company Xspray Pharma in connection with a directed…
Vinge has advised EQT AB (publ) (“EQT”) in connection with the offering and listing on Nasdaq Stockh…
